Trimedyne, Inc. reported unaudited consolidated earnings results for the first quarter ended December 31, 2017. For the quarter, the company had revenues of $1,534,000, an increase of 40% from revenues of $1,094,000 for the prior year quarter. The company had a net income for the current quarter of $86,000 or $0.70 per share, as compared to a net loss of $225,000 or $1.83 per share for the prior year quarter. This 138% increase in net income as compared to the prior year quarter is a considerable improvement, which was primarily the result of an increase in sales revenue and the continuation of cost controls. Income before income taxes was $88,000 against loss of $223,000 a year ago.